Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Voyager Therapeutics, Inc. | 100,000 | reported | 06 Jan 2026 | tx 1+100,000 |
| Sage Therapeutics, Inc. | 0 | reported | 31 Jul 2025 | tx 16+57,525−72,492 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | GRANT_AWARD | Voyager Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 31 Jul 2025 | TENDER | Sage Therapeutics, Inc. | 7,215 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 23,735 | — | |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 28,000 | — | deriv |
| 31 Jul 2025 | OTHER | Sage Therapeutics, Inc. | 10,000 | — | deriv |
| 24 Jun 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 79 | 9.22 USD | |
| 10 Apr 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 525 | 0.00 USD | |
| 10 Apr 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 176 | 6.91 USD | |
| 24 Mar 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 79 | 8.21 USD | |
| 24 Feb 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 2,502 | 7.49 USD | |
| 13 Feb 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 251 | 7.18 USD | |
| 13 Feb 2025 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 376 | 7.18 USD | |
| 16 Jan 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 14,000 | 0.00 USD | |
| 16 Jan 2025 | GRANT_AWARD | Sage Therapeutics, Inc. | 28,000 | 0.00 USD | deriv |
| 24 Dec 2024 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 79 | 5.48 USD | |
| 01 Nov 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 5,000 | 0.00 USD | |
| 01 Nov 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |